TCI GENE Inc. (6879.TWO)
TWD 42.3
(3.17%)
TWD 42.3
(3.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -689.25 Million TWD | 25.91% |
| 2022 | -930.26 Million TWD | -192.61% |
| 2021 | -317.91 Million TWD | -79.64% |
| 2020 | -176.97 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -238.05 Million TWD | 1.33% |
| 2024 Q1 | -242.62 Million TWD | 64.8% |
| 2023 FY | -689.25 Million TWD | 25.91% |
| 2023 Q2 | -814.34 Million TWD | 0.78% |
| 2023 Q1 | -820.71 Million TWD | 11.78% |
| 2023 Q3 | -696.04 Million TWD | 14.53% |
| 2023 Q4 | -689.25 Million TWD | 0.98% |
| 2022 Q4 | -930.26 Million TWD | 0.27% |
| 2022 Q3 | -932.73 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -160.913% |
| Level Biotechnology Inc. | -453.9 Million TWD | -51.85% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -471.66% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -250.948% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 237.892% |
| GlycoNex Incorporation | -148.56 Million TWD | -363.933% |
| VBI | -25.31 Million TWD | -2622.59% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 1811.744% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 599.475% |
| Visgeneer Inc. | 31.28 Million TWD | 2303.206% |
| Mycenax Biotech Inc. | 207 Million TWD | 432.957% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | -1.27% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -413.401% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 210.895% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -1095.413% |
| Enimmune corporation | -314.15 Million TWD | -119.396% |
| TaiRx, Inc. | -147.86 Million TWD | -366.123% |
| CHO Pharma, Inc. | -203.79 Million TWD | -238.213% |
| EirGenix Inc. | -4.58 Billion TWD | 84.977% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -713.151% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 670.237% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 78.583% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -117.143% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -3378.782% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 2266.843% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 1457.996% |
| RBC Bioscience Corporation | 422.18 Million TWD | 263.258% |
| BiOptic Inc. | 12.59 Million TWD | 5573.721% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 27.017% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -579.159% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -317.283% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 318.898% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -794.62% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -162.49% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 2354.075% |
| Neith Corporation | -150.31 Million TWD | -358.55% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -971.58% |
| NaviFUS Corp. | -123.12 Million TWD | -459.78% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 1030.779% |
| Sinew Pharma Inc. | -160.34 Million TWD | -329.855% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -184.94% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -104.299% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -67.035% |
| AP Biosciences Inc | -196.52 Million TWD | -250.714% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 200.075% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -5926.502% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 16.927% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 150.78% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | -66.133% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -229.253% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -379.102% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -108.521% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -479.504% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 47.354% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 3464.99% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -576.599% |
| PharmaEngine, Inc. | -860.8 Million TWD | 19.93% |
| Savior Lifetec Corporation | -812.54 Million TWD | 15.174% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -129.775% |
| OBI Pharma, Inc. | -398.22 Million TWD | -73.081% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | -88.619% |
| Acepodia, Inc. | -6.02 Billion TWD | 88.551% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 79.738% |